Mirvetuximab (M9346A) is an anti-FOLR1 (folate receptor 1) monoclonal antibody. Mirvetuximab is the antibody moiety of novel folate receptor alpha (FRalpha)-targeting ADC (Mirvetuximab soravtansine). Mirvetuximab soravtansine can be used in ovarian and other FRalpha-positive cancer research.
Purity:
99.5%
CAS Number:
[1453084-36-0]
Target:
Antifolate
* VAT and and shipping costs not included. Errors and price changes excepted